FRE Share Price Performance
AU$0.064
0.01 (12.28%)
Price AU$0.064
Share PriceAU$0.064
Firebrick Pharma Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
FRE Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Firebrick Pharma Limited Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -0.011
- 63.41%
- -511.04%
- 0%
About FRE
- Founded
- 2012
- Employees
- n/a
- CEO
- WebsiteView website
Firebrick Pharma Limited engages in the development and commercialization of povidone-iodine (PVP-I) products under the Nasodine brand in Asia, North America, Europe, and internationally. It offers nasal spray PVP-I products for the treatment of common cold. The company was incorporated in 2012 and is based in Melbourne, Australia.
